These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6620688)

  • 1. [Hyperprolactinemia and guanidinosuccinic acid in chronic renal failure].
    Fujimura A; Kawato M; Nakabayashi H; Tofuku Y; Noto M; Akiyama T; Kido C; Kuroda M; Takeda R
    Nihon Jinzo Gakkai Shi; 1983 Feb; 25(2):199-204. PubMed ID: 6620688
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on guanidine compounds in uremia: reevaluation of serum GSA in relation to acute symptoms of uremia (author's transl)].
    Tofuku Y; Kuroda M; Kita T; Takeda R
    Nihon Jinzo Gakkai Shi; 1980 Mar; 22(3):249-58. PubMed ID: 7382166
    [No Abstract]   [Full Text] [Related]  

  • 3. Guanidinosuccinic acid and transketolase.
    Stein IM
    N Engl J Med; 1971 Sep; 285(11):637. PubMed ID: 5563971
    [No Abstract]   [Full Text] [Related]  

  • 4. [Platelet aggregation in chronic renal failure--whole blood aggregation and effect of guanidino compounds].
    Maejima M; Takahashi S; Hatano M
    Nihon Jinzo Gakkai Shi; 1991 Feb; 33(2):201-12. PubMed ID: 2051648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A striking rise of serum guanidinosuccinic acid (s-GSA) in the critical period of CRF].
    Haruki K; Hirata M; Muramoto H; Tofuku Y; Takeda R
    Nihon Jinzo Gakkai Shi; 1988 Jul; 30(7):821-5. PubMed ID: 3249449
    [No Abstract]   [Full Text] [Related]  

  • 6. [Guanidino compounds and aliphatic monoamines in acute and chronic renal failure].
    Suzuki Y
    Nihon Jinzo Gakkai Shi; 1992 Oct; 34(10):1077-85. PubMed ID: 1289608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the role of active oxygen in guanidine synthesis in haemodialysis patients and in vitro.
    Nagase S; Aoyagi K; Sakamoto M; Narita M; Tojo S
    Nephrol Dial Transplant; 1988; 3(6):790-4. PubMed ID: 3147421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methylguanidine dialysis and the hypothesis of the mean molecules].
    Barsotti G; Rindi P
    Minerva Nefrol; 1974; 21(4):270-4. PubMed ID: 4467048
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chronic renal failure and guanidino compounds].
    Kinoshita T
    Yakugaku Zasshi; 1997 Nov; 117(10-11):673-80. PubMed ID: 9414581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guanidino compounds in uraemic dialysed patients.
    De Deyn P; Marescau B; Lornoy W; Becaus I; Lowenthal A
    Clin Chim Acta; 1986 Jun; 157(2):143-50. PubMed ID: 3719996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guanidinosuccinic acid in renal failure, experimental azotemia and inborn errors of the urea cycle.
    Stein IM; Cohen BD; Kornhauser RS
    N Engl J Med; 1969 Apr; 280(17):926-30. PubMed ID: 5775630
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies of the effects of low-molecular uremic toxins on anaerobic metabolism of human erythrocytes].
    Kopczyński Z; Dryl-Rydzyńska T
    Pol Arch Med Wewn; 1991 Oct; 86(4):232-8. PubMed ID: 1813877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostaglandin metabolism in blood platelets and guanidine level in patients with chronic uremia].
    Komarnicki M; Pietrzak I; Zozulińska M; Czarnecki R; Antoniewicz K; Baczyk K
    Pol Arch Med Wewn; 1984 Nov; 72(5):243-7. PubMed ID: 6535143
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered guanidino compound concentrations.
    De Deyn PP; Robitaille P; Vanasse M; Qureshi IA; Marescau B
    Nephron; 1995; 69(4):411-7. PubMed ID: 7777105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automatic system for the assay of guanidino compounds to assess uremic status and effect of hemodialysis.
    Nohara Y; Hanai T; Suzuki J; Matsumoto G; Iinuma F; Kubo H; Kinoshita T
    Chem Pharm Bull (Tokyo); 1998 Nov; 46(11):1844-5. PubMed ID: 9845964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of guanidino compounds in non-dialyzed patients with chronic renal failure.
    Ikezaki N
    Nihon Jinzo Gakkai Shi; 1990 Mar; 32(3):283-90. PubMed ID: 2355664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short term effect of lactulose therapy in patients with chronic renal failure.
    Miura M; Nomoto Y; Sakai H
    Tokai J Exp Clin Med; 1989 Mar; 14(1):29-34. PubMed ID: 2699952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Guanidine succinate in acute and chronic uremia].
    Gróf J; Tankó A; Menyhárt J; Csata S
    Orv Hetil; 1974 Jan; 115(2):74-7. PubMed ID: 4839162
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential removal of guanidinosuccinic acid and creatine by hemodialysis and continuous ambulatory peritoneal dialysis.
    De Deyn PP; Marescau B; Swartz RD; Billiouw JM; Becaus I; Lornoy W
    Nephron; 1991; 57(3):369-70. PubMed ID: 2017282
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of long term dialysis therapy on blood prolactin patients with chronic renal failure].
    Pachelski J; Kokot F; Grzeszczak W
    Pol Tyg Lek; 1989 Feb; 44(9):214-6. PubMed ID: 2813182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.